Search

Juliet M Nabakka

from San Diego, CA
Age ~49
Get Report
Also known as:
Juliet N Nabakka, Juliet Makubuya Thomgoulding
Phone and address:
9855 Fieldthorn St, San Diego, CA 92127
(858) 451-2295
Related to:
James Kika Makubuya, 79Annette M Nakku, 50Tofowa Thom-Goulding, 48Mwanza ThomgouldingGoulding Kareema Thom, 50Goulding T Tafowa, 49Ancella Thom Golding, 41Mwanza Goulding, 52T O ThomgouldingMargaret N Makubuya
Connected to:
Timothy Nabal, 88Jumana M Nabali, 62Cassandra A Nabalta, 45Kaustubh N Nabar, 37Dominique A Nabarowsky, 40Stephen J Nabarowsky, 66Bruce A Nabat, 74Craig B Nabat, 53Marilou M Nabatilan, 54Carlina R Nabatoff, 55

Juliet Nabakka Phones & Addresses

  • 9855 Fieldthorn St, San Diego, CA 92127 (858) 451-2295
  • 6120 Decena Dr, San Diego, CA 92120 (619) 521-8559 (858) 795-7964
  • 10107 Carefree Dr, Santee, CA 92071 (619) 596-1502
  • Durham, NC
  • Chapel Hill, NC
  • Alta Loma, CA

Work

Company: Gnf Sep 2002 Position: Scientist ii

Education

Degree: Bachelors, Bachelor of Science School / High School: University of California, Los Angeles Specialities: Chemistry

Industries

Biotechnology

Resumes

Resumes

Juliet Nabakka Photo 1

Scientist Ii

View page
Location:
San Diego, CA
Industry:
Biotechnology
Work:
Gnf
Scientist Ii
Eli Lilly and Company May 2001 - Jul 2002
Research Associate
Education:
University of California, Los Angeles
Bachelors, Bachelor of Science, Chemistry University of North Carolina at Chapel Hill
Master of Science, Masters, Chemistry

Publications

Us Patents

Diarylamine-Containing Compounds And Compositions, And Their Use As Modulators Of C-Kit Receptors

View page
US Patent:
7514447, Apr 7, 2009
Filed:
Sep 26, 2006
Appl. No.:
11/535455
Inventors:
Valentina Molteni - San Diego CA, US
Xiaolin Li - San Diego CA, US
Donatella Chianelli - San Diego CA, US
Jon Loren - San Diego CA, US
Juliet Nabakka - Santee CA, US
Xiadong Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Yi Liu - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Pascal Furet - Thann, FR
Vito Guagnano - Basel, CH
Shuli You - Shanghai, CN
Assignee:
IRM LLC - Hamilton
Novartis AG - Basel
International Classification:
C07D 239/42
C07D 403/10
C07D 403/14
A61K 31/505
A61K 31/506
A61P 35/00
US Classification:
514275, 544330
Abstract:
Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

Diarylamine-Containing Compounds And Compositions, And Their Use As Modulators Of C-Kit Receptors

View page
US Patent:
7563894, Jul 21, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/932945
Inventors:
Valentina Molteni - San Diego CA, US
Shuli You - Shanghai, CN
Juliet Nabakka - Santee CA, US
Yi Liu - San Diego CA, US
Xiaolin Li - San Diego CA, US
Donatella Chianelli - San Diego CA, US
Jon Loren - San Diego CA, US
Xiaodong Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Pascal Furet - Thann, FR
Vito Guagnano - Basel, CH
Assignee:
IRM LLC - Hamilton
Novartis AG - Basel
International Classification:
C07D 403/10
C07D 403/14
C07D 239/42
A61K 31/505
US Classification:
544330, 514275
Abstract:
Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

Bicyclic Compounds And Compositions As Pdf Inhibitors

View page
US Patent:
7579363, Aug 25, 2009
Filed:
Jun 27, 2007
Appl. No.:
11/769679
Inventors:
Valentina Molteni - San Diego CA, US
Xiaohui He - San Diego CA, US
Yun He - San Diego CA, US
Andreas Kreusch - San Diego CA, US
Juliet Nabakka - San Diego CA, US
Kunyong Yang - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 417/12
C07D 279/16
A61K 31/5415
US Classification:
514312, 546158
Abstract:
This invention is directed to novel bicyclic compounds, to the uses of these compounds in various medicinal applications, including treating disorders amenable to treatment by peptidyl deformylase inhibitors such as treatment of bacterial infections, and to pharmaceutical compositions comprising these compounds.

Diarylamine-Containing Compounds And Compositions, And Their Use As Modulators Of C-Kit Receptors

View page
US Patent:
7592349, Sep 22, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/933056
Inventors:
Valentina Molteni - San Diego CA, US
Shuli You - Shanghai, CN
Juliet Nabakka - Santee CA, US
Yi Liu - San Diego CA, US
Xiaolin Li - San Diego CA, US
Donatella Chianelli - San Diego CA, US
Jon Loren - San Diego CA, US
Xiaodong Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Pascal Furet - Thann, FR
Vito Guagnano - Basel, CH
Assignee:
IRM LLC - Hamilton
Novartis AG - Basel
International Classification:
A61K 31/505
A61K 31/506
C07D 239/42
C07D 403/04
C07D 403/14
A61P 35/00
US Classification:
514275, 544330, 544331, 544332
Abstract:
Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

Diarylamine-Containing Compounds And Compositions, And Their Use As Modulators Of C-Kit Receptors

View page
US Patent:
7638523, Dec 29, 2009
Filed:
Oct 31, 2007
Appl. No.:
11/933030
Inventors:
Valentina Molteni - San Diego CA, US
Shuli You - Shanghai, CN
Juliet Nabakka - Santee CA, US
Yi Liu - San Diego CA, US
Xiaolin Li - San Diego CA, US
Donatella Chianelli - San Diego CA, US
Jon Loren - San Diego CA, US
Xiaodong Liu - San Diego CA, US
Shifeng Pan - San Diego CA, US
Donald S. Karanewsky - Escondido CA, US
Pascal Furet - Thann, FR
Vito Guagnano - Basel, CH
Assignee:
IRM LLC - Hamilton
Novartis AG - Basel
International Classification:
A61K 31/505
A61K 31/506
A61P 19/02
A61P 37/08
A61P 9/02
A61P 17/06
A61P 1/04
A61P 1/16
A61P 25/20
C07D 239/42
C07D 403/10
C07D 403/14
US Classification:
514275, 544330
Abstract:
Described herein are compounds that include a diarylamine structural feature. Also described herein are methods for making such compounds, methods for using such compounds to modulate the activity of c-kit receptors, and pharmaceutical compositions and medicaments comprising such compounds. Also described herein are methods of using such compounds, pharmaceutical compositions and medicaments to treat and/or prevent and/or inhibit and/or ameliorate the pathology and/or symptomology diseases or conditions associated with the activity of c-kit receptors.

Compositions And Methods For Modulating C-Kit And Pdgfr Receptors

View page
US Patent:
7678792, Mar 16, 2010
Filed:
Oct 16, 2007
Appl. No.:
11/873196
Inventors:
Donatella Chianelli - San Diego CA, US
Christopher Cow - San Diego CA, US
Yun He - Shanghai, CN
Songchun Jiang - San Diego CA, US
Xiaolin Li - San Diego CA, US
Xiaodong Liu - San Diego CA, US
Zuosheng Liu - San Diego CA, US
Jon Loren - San Diego CA, US
Valentina Molteni - San Diego CA, US
Juliet Nabakka - Santee CA, US
Pingda Ren - San Diego CA, US
Taebo Sim - Seoul, KR
Xiaodong Wang - Chapel Hill NC, US
Shuli You - Shanghai, CN
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 471/04
A61K 31/4375
A61K 31/497
A61K 31/501
A61K 31/5355
A61K 31/506
C07D 413/14
C07D 213/69
C07D 213/61
C07D 213/74
C07D 213/80
C07C 205/06
C07C 301/00
C07C 255/07
C07C 69/73
A61P 17/10
A61P 29/00
A61P 3/10
A61P 31/00
A61P 27/14
US Classification:
5142325, 514300, 51425304, 51425204, 5142345, 514275, 544362, 544238, 544127, 544331, 544 80, 544119, 546296, 546318, 546310, 546297, 546122, 568705, 558 44, 558410, 560 60
Abstract:
The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit, PDGFRα, PDGFRβ, CSF1R, Abl, BCR-Abl, CSK, JNK1, JNK2, p38, p70S6K, TGFβ, SRC, EGFR, trkB, FGFR3, FLT3, Fes, Lck, Syk, RAF, MKK4, MKK6, SAPK2β, BRK, KDR, c-raf or b-raf kinase, or mutant forms thereof.

Compounds And Compositions As Lxr Modulators

View page
US Patent:
7846949, Dec 7, 2010
Filed:
Feb 11, 2005
Appl. No.:
10/589410
Inventors:
Valentina Molteni - San Diego CA, US
Xiaolin Li - Del Mar CA, US
Fang Liang - Carlsbad CA, US
Juliet Nabakka - Santee CA, US
Enrique Saez - San Diego CA, US
John Wityak - Carlsbad CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
A61K 31/44
A61K 31/42
A61K 31/41
C07D 213/55
C07D 498/00
C07D 231/12
C07C 229/00
US Classification:
514357, 514378, 514406, 514359, 546335, 548242, 5483731, 560 41
Abstract:
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).

Compositions And Methods For Modulating C-Kit And Pdgfr Receptors

View page
US Patent:
8106068, Jan 31, 2012
Filed:
Dec 2, 2009
Appl. No.:
12/629665
Inventors:
Zuosheng Liu - San Diego CA, US
Jon Loren - San Diego CA, US
Valentina Molteni - San Diego CA, US
Juliet Nabakka - San Diego CA, US
Assignee:
IRM LLC - Hamilton
International Classification:
C07D 471/04
A61K 31/4375
A61P 29/00
A61P 25/28
A61P 25/04
A61P 35/00
A61P 9/12
A61P 9/00
US Classification:
514300, 546123
Abstract:
The invention provides compounds of Formula (2), and pharmaceutical compositions thereof,.
Control profile
Juliet M Nabakka from San Diego, CA, age ~49 Get Report